ARTICLESPlasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
References (3)
- et al.
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition.
Lancet
(1991) - et al.
Neuroendocrine activation after acute myocardial infarction
Br Heart J
(1988)
There are more references available in the full text version of this article.
Cited by (214)
Biomarkers in Heart Failure: Clinical Insights
2021, Heart Failure ClinicsValue of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome
2014, Journal of the Saudi Heart AssociationNatriuretic peptides and cerebral hemodynamics
2014, Regulatory PeptidesBrain natriuretic peptide in cardiovascular diseases
2008, American Journal of the Medical SciencesShort-Term Serial Sampling of Natriuretic Peptides in Patients Presenting With Chest Pain
2007, Journal of the American College of CardiologyThe role of B type natriuretic peptide in the assessment of post myocardial infarction prognosis
2006, Annales de Cardiologie et d'Angeiologie
Copyright © 1993 Published by Elsevier Ltd.